Categories: Healthcare

Sciatica Market Analysis, Share, Drivers, Growth 2024-2033

Overview and Scope

Sciatica refers to pain that describes the inflammation, irritation, pinching, or compression that occurs in the leg due to pressure or injury to the sciatic nerve. Physical therapy can treat sciatica as it improves range of motion, flexibility and strength while alleviating pressure on the sciatic nerve.

Sizing and Forecast

The sciatica market size has grown strongly in recent years. It will grow from $6.52 billion in 2023 to $6.93 billion in 2024 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to innovative pain management solutions, digital health, telemedicine, personalized treatment approaches, integrative care models.

The sciatica market size is expected to see strong growth in the next few years. It will grow to $8.59 billion in 2028 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to personalized medicine, telemedicine and remote procedures, patient education and awareness, reimbursement policies. Major trends in the forecast period include advanced diagnostic imaging, regenerative medicine, digital therapeutics, preventive measures.

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/sciatica-global-market-report

Segmentation & Regional Insights

The sciatica market covered in this report is segmented –

1) By Type: Acute Sciatica; Chronic Sciatica; Other Types

2) By Drugs: Oxycodone; Tramadol; Opioid Analgesics; Amitriptyline; Tricyclic Antidepressants; Other Drugs

3) By Treatment: Medication; Surgery

4) By End Users: Hospitals; Homecare; Specialty Clinics; Other End Users

North America was the largest region in the sciatica market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in sciatica market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13000&type=smp

Major Driver Impacting Market Growth

The increasing number of orthopedic procedures is expected to propel the growth of the sciatica market going forward. Orthopedic procedures refer to operations used to treat conditions affecting the spine and joints and correct skeletal malformations. Sciatica treatment provides improved pain relief, restores mobility and function and thereby improves the quality of life for patients suffering from sciatica. Orthopedic doctors and surgeons are often involved in the diagnosis and treatment of sciatica. For instance, in February 2023, according to research published by the National Library of Medicine, a US-based biomedical library, total hip arthroplasty (THA) and total knee arthroplasty (TKA) procedures are expected to increase by 719,364 and 1,222,988, respectively, by the year 2040. Moreover, TKAs are anticipated to total 2,917,959 by 2060, whereas THAs are anticipated to total 1,982,099 by that time. Therefore, the increasing number of orthopedic procedures is driving the growth of the sciatica market.

Key Industry Players

Major players in the sciatica market are Pfizer Inc., Merck and Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi-Aventis LLC., AstraZeneca PLC, GlaxoSmithKline plc., Eli Lilly and Co Ltd., Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Macleods Pharmaceuticals Limited, Sun Pharmaceutical Industries Limited, Dr. Reddy’s Laboratories Ltd., Aurobindo Pharma Ltd., Intas Pharmaceuticals Ltd., Hikma Pharmaceuticals PLC, Cipla Inc., Endo International PLC, Amneal Pharmaceuticals Inc., Aspen Pharmacare Holdings Limited, Zydus Lifesciences Ltd., Lupin Limited, Alkem Laboratories Limited, Torrent Pharmaceuticals Ltd.

The sciatica market report table of contents includes: